出版应用/物种/样本/稀释 | 参考文献 |
---|
| McCord M, Steffens A, Javier R, Kam K, McCortney K, Horbinski C. The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas. Acta Neuropathol Commun. 2020;8:15 pubmed 出版商
|
- 免疫组化-石蜡切片; 人类; 1:100; 图 s1
| Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed 出版商
|
| Gaifulina R, Caruana D, Oukrif D, Guppy N, Culley S, Brown R, et al. Rapid and complete paraffin removal from human tissue sections delivers enhanced Raman spectroscopic and histopathological analysis. Analyst. 2020;145:1499-1510 pubmed 出版商
|
| Cheng A, Leung S, Gao D, Burugu S, Anurag M, Ellis M, et al. Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort. Breast Cancer Res Treat. 2020;179:3-10 pubmed 出版商
|
| Pearlman R, Haraldsdottir S, de la Chapelle A, Jonasson J, Liyanarachchi S, Frankel W, et al. Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome. J Med Genet. 2019;56:462-470 pubmed 出版商
|
| Eriksen A, Sørensen F, Lindebjerg J, Hager H, dePont Christensen R, Kjær Frifeldt S, et al. Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort. BMC Cancer. 2019;19:142 pubmed 出版商
|
| Hansen T, Kjær Frifeldt S, Eriksen A, Lindebjerg J, Jensen L, Sørensen F, et al. Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts. Br J Cancer. 2018;119:1367-1373 pubmed 出版商
|
| Tessier Cloutier B, Kalloger S, Al Kandari M, Milne K, Gao D, Nelson B, et al. Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma. BMC Cancer. 2017;17:618 pubmed 出版商
|
| Knudsen K, Nielsen B, Lindebjerg J, Hansen T, Holst R, Sørensen F. microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution. PLoS ONE. 2015;10:e0140503 pubmed 出版商
|
| Seppälä T, Böhm J, Friman M, Lahtinen L, Väyrynen V, Liipo T, et al. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Br J Cancer. 2015;112:1966-75 pubmed 出版商
|
| Williams D, Bird M, Jorissen R, Yu Y, Walker F, Walker F, et al. Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability. PLoS ONE. 2010;5:e16012 pubmed 出版商
|